Investing

Investment analysis, share recommendations, and market insights.

Premium

Three cancer stocks

Cancer is one of the most interesting areas of work of the ASX’s growing cohort of life sciences companies. Here are three of the fascinating stories emerging from this area.

James Dunn · May 26, 2025
Premium

“HOT” stock: Resolute Mining (RSG)

In our “HOT” stock article today, Michael Gable, Managing Director of Fairmont Equities, says he’s still bullish on gold and because the trend looks positive for Resolute Mining (RSG), he thinks at current levels RSG is a buying opportunity.

Maureen Jordan · May 22, 2025
Premium

This rally has legs but I’m not sure how to use them

The history of stock markets crashing and then bouncing back big time says we should believe this rally has legs, but should we be thinking “this time it’s different”? Should I be investing for growth or going defensive right now?

Peter Switzer · May 19, 2025
Premium

Why can’t the market sell CBA?

Today I want to address two of the most widely asked questions by investors: Why can’t the market sell CBA? And Why is this bank so expensive? And I tell you how I think you should play CBA!

Paul Rickard · May 19, 2025
Premium

3 stocks under $20

Here are three stocks poised to smash through the $20 level in share price – in the cases of Orica and Northern Star, heading back above $20.

James Dunn · May 19, 2025
Premium

How to add a touch of royalty in volatile markets

Some overseas royalty companies have been excellent investments and look like a good bet in volatile markets. Although having a low market profile, they can be attractive long-term investments. Here are two royalty plays that could be sources of income for long-term investors.

Tony Featherstone · May 15, 2025

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.